#healthtech #obesitycare #servicedesign #nhs To view or add a comment, sign in GLP-1s Are Not Miracle Drugs Theyre Powerful Tools When Used Correctly Key takeaways from this timely National Academy of Medicine discussion: - GLP-1based therapies can be highly effective, but expectations must align with the evidence - Obesity is a chronic disease, not a short-term condition solved by medication alone - Safety, access, and cost remain central challenges - Medications work best when embedded in comprehensive, wraparound care - Addressing stigma is as important as addressing biology Grateful to be part of this thoughtful conversation moderated by Alex Azar, with Govind Persad, Jeffrey Singer, and Tracy Zvenyach, PhD, MS, RN #GLP1 #ObesityCare #PublicHealth #HealthPolicy Are GLP-1 drugs miracle medications, or are expectations getting ahead of the evidence
For lupus patients, GI symptoms deserve extra scrutiny because lupus can independently cause GI inflammation, gastroparesis, and serositis
Without those details, the access picture remains incomplete
Such AngII-induced spatial memory impairment has also been reported in rats following acute intracerebroventricular infusion (79)
As more patients turn to GLP1 medications, CVS Pharmacy is emphasizing the role of its pharmacists in helping patients navigate treatment
